Rapid clinical evidence summary for landmark cardiovascular outcomes trial (CVOT): field-ready within 72 hours of publication
Publication day is a scientific event and a competitive event simultaneously
Cardiovascular outcomes trials are high-visibility scientific events. When a major CVOT publishes, cardiologists read the New England Journal of Medicine before their MSL team has been briefed. Within 48 hours of publication, the trial's findings are being discussed at cardiology grand rounds, department meetings, and informal conversations between clinicians.
For a brand with a cardiovascular product in the same class, this window is critical. If the MSL team cannot engage meaningfully with the new data in those first conversations, they cede the scientific narrative to their cardiologist customers — who will interpret the data without the brand's contextual framing.
The brand had a standard congress response protocol, but a landmark publication required a different kind of response — faster, more targeted, and calibrated specifically for the field conversation context rather than the academic review context.
Your cardiologists will read the NEJM paper on Sunday. Your MSLs need to be ready to discuss it with them on Monday. The window between publication and the first KOL conversation is where the scientific narrative is shaped.
What we did
Measurable impact
The clinical summary, MSL talking points, and FAQ were distributed to all field teams 68 hours after publication — within the 72-hour target. MSL teams entering scheduled KOL meetings that week were fully briefed. Post-distribution feedback from field medical directors indicated that cardiologists in multiple markets were receptive to the brand's contextual framing of the new data. The pre-publication preparation model was adopted as standard practice for all future high-priority publication monitoring.
Tell us what you’re working on — we’ll show you relevant cases and suggest the fastest path forward.
From the field:
evidence & practice
AI-powered.
Expert-validated.
We built AI workflows into our daily practice — not as a marketing claim, but as the infrastructure that lets our medical experts deliver faster without cutting corners.
